Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of CKD-828 (S-amlodipine + telmisartan) vs S-amlodipine in inadequately controlled hypertension
KCT0000321Phase 3Completed
- Sponsor
- Chong Kun Dang
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan + s-amlodipine in essential hypertension, sponsored by Chong Kun Dang. Started Aug 2011; status: completed.
02
Drugs
telmisartan + s-amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on KCT0000321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000321.